Found 48 results in Expert Content

Summary: In this Q&A article, experts discuss intranasal drug product development, in particular best practices and key considerations, from formulation design to manufacture and scale-up.

Summary: In this Q&A article, Catalent experts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.

Intranasal delivery is emerging as an alternative route of systemic drug delivery for a variety of indications such as migraine, seizures, breakthrough pain and opioid overdose and more.

Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...

Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications.

Explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung regions.

Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...

Summary: Catalent expands its inhalation platform through the acquisition of a Boston-area facility, providing spray drying, powder encapsulation and blister packaging for Dry Powder Inhaler (DPI) capsules.

This article discusses how quality by design (QbD) can be built into inhalation product development to ensure a drug and device are safe and effective.

Summary: Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs.  New products are increasingly...